sign骨质疏松的管理与脆性折的预防.pptx

Management of osteoporosis and theprevention of fragility fractures;LEVELS OF EVIDENCE;The need for a guideline; 2 Key recommendations;2 Key recommendations; 2 Key recommendations;2 Key recommendations;3 Risk factors;Risk factors;3.2non-modifiable risk factors;non-modifiable risk factors;3.2.4 previous fracture;3.2.5 Family history;3.2.6Reproductive factors生殖因素;33.modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变风险;modifiable risk factors可变???险;modifiable risk factors可变风险;modifiable risk factors可变风险;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;3.5 pharmacologica l risk factors药物危险因素;4 Quantifying the risk of fracture;4 Quantifying the risk of fracture;4 Quantifying the risk of fracture;4 Quantifying the risk of fracture;4 Quantifying the risk of fracture;4 Quantifying the risk of fracture;4 Quantifying the risk of fracture; 5 Targeting treatment; 5 Targeting treatment; 5 Targeting treatment; 5 Targeting treatment;5 Targeting treatment;6 Management of osteoporosis in postmenopausal women;6 Management of osteoporosis in postmenopausal women;6 Management of osteoporosis in postmenopausal women;6 Management of osteoporosis in postmenopausal women;6 Management of os